Navigation Links
Heartburn Sufferers Find Lasting Relief With TUMS(R) Dual Action
Date:4/8/2009

One tablet goes to work in seconds to relieve heartburn all day or all night

PITTSBURGH, April 8 /PRNewswire/ -- Approximately 60 million Americans experience heartburn at least once a month. For those sufferers whose occasional heartburn gets in the way of life, TUMS(R), the best selling antacid in America, is introducing a new, long-lasting treatment. TUMS Dual Action, just like all TUMS, goes to work in seconds but also lasts for hours -- all day or all night -- offering heartburn sufferers long-lasting relief without compromise.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090408/NY96327)

TUMS Dual Action contains calcium carbonate, the same trusted ingredient as the regular TUMS that Americans have depended upon for the past 75 years. TUMS Dual Action also includes an additional antacid ingredient, magnesium hydroxide, and 10 mg of famotidine, a safe and effective acid reducer, to help keep heartburn from coming back, making it the longest lasting TUMS ever. Available in Berry or Mint flavor, the one-dose chewable tablet immediately neutralizes acid on contact. Like all TUMS, it is also an excellent source of calcium, with 320 mg of elemental calcium per tablet.

"TUMS Dual Action is a natural extension for the iconic TUMS brand, offering a proven solution for occasional heartburn sufferers looking for long-lasting relief from a trusted source," says Jack Levy, TUMS Brand Manager at GlaxoSmithKline Consumer Healthcare. "With it, heartburn sufferers won't need to think about whether or not lunchtime heartburn will interrupt dinner, or whether they'll be able to sleep without being bothered by heartburn."

A Perfect Partner when Heartburn Breaks Through

In addition to providi
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Blood Thinner, Heartburn Drugs May Be Risky After Heart Attack
2. Plavix Plus Heartburn Drugs May Hike Heart Risk
3. CHPA, Nielsen: OTC Heartburn Therapy Saves Nearly $800 Million Annually, Vast Majority of OTC Heartburn Consumers Satisfied
4. Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
5. First Over-The-Counter Store Brand Omeprazole Offering in U.S. Market Creates New Option for Frequent Heartburn Sufferers
6. AUDIO from Medialink and Prilosec OTC: Recipes for Heartburn-Friendly Super Bowl Snacking
7. FDA Confirms No Heart Risk From Heartburn Drugs
8. Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays
9. Heartburn Can Be a Sign of Serious Disease
10. Chronic Pain Sufferers Report Relief: DRJ Group Teams With Adult Foster Care Facilities to Evaluate Effectiveness of Stopain Topical Analgesic
11. Actress and Mom Alison Sweeney Teams Up With the American Pharmacists Association to Help Fellow Allergy Sufferers Find Relief This Spring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Developers and plugin specialist of Final Cut Pro ... FCPX to the next level. , “ProPip allows users to ... of a mouse,” said Christina Austin, CEO of Pixel Film ... appreciate.” , With ProPip users can show off their ... ProPip is great for commentaries, news casting, and more. PROPIP™ ...
(Date:11/27/2014)... 2014 Aria Health President and ... prepared and donated 200 Thanksgiving dinners on Friday, ... , a non-profit, community-based organization committed to serving ... The dinners were assembled in the dining hall ... distributed to vulnerable low income seniors in the ...
(Date:11/27/2014)... New Delhi, India (PRWEB) November 27, 2014 ... firm, has announced a search engine optimization service ... that small businesses or start-ups cannot afford costly ... introduced this service package, keeping their affordablity and ... reduced the service cost, but it has not ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VeloReality Inc. ... six new Real Life Videos (RLVs) of world-famous velo courses ... Trainer, as well as other popular indoor velo trainers. Two ... available worldwide before the end of November -- in ... the total number of rides in the VeloReality collection to ...
(Date:11/26/2014)... Il (PRWEB) November 27, 2014 ... excited to announce the kick-off of its annual ... encourages people to go to donate to those ... partner with local organizations to distribute the donations ... 20th, participating AlignLife locations will be accepting donations ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3Health News:Aria Health Prepares and Donates 200 Thanksgiving Dinners 2Health News:RBSEO Services Announces SEO Services at $99 Only 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3
... the heart's natural electrical signaling process. The director ... a faculty member in the biomedical engineering department. ... of the human heart have fascinated poets, lovers ... deepest secrets remain tightly locked. Tulane biomechanical engineer ...
... the skin- and flesh-destroying Bairnsdale ulcer has struck a ... publish new recommendations for treating the tropical infection. // ... ulcer, Bairnsdale ulcers are caused by Mycobacterium ulcerans ... tissue, and sometimes bone. ,Associate Professor Paul ...
... scientists at the Vanderbilt Kennedy Center for Research on ... exposure to cocaine and behavioral //and neurological problems in ... Journal of Neuroscience, Gregg Stanwood, Ph.D., and Pat Levitt, ... to cocaine in rabbits, which caused a prolonged displacement ...
... by researchers at the Kimmel Cancer Center at Thomas ... shows that pancreatic cancer patients //65 or older who ... as good a chance as anyone else to live ... records of 890 patients with pancreatic cancer who underwent ...
... can cause subtle but disabling cognitive impairments -- ... Says a recent study by investigators. ... for Research on Human Development may help explain ... prenatal exposure to cocaine. In a recent issue ...
... domestic violence, and health care disparities are among the ... of Nursing (JHUSON) are exploring in efforts to care ... variety of audiences. ,Sick at Heart —JHUSON Associate ... issue of 'moral distress' experienced by many nurses, including ...
Cached Medicine News:Health News:Secrets of the Heart's Signals 2Health News:Skin-Destroying Ulcer Appears in NSW as New Treatment Guidelines Emerge 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 2Health News:Cocaine During Pregnancy can Cause Behavioral and Neurological Problems in the Child 3Health News:Study: Older Pancreatic Cancer Surgery Survivors Live Long 2Health News:Cocaine's Use During Pregnancy May Cause Lasting Cellular Effects 2Health News:Cocaine's Use During Pregnancy May Cause Lasting Cellular Effects 3Health News:Nurses Ease the Wounded Heart 2Health News:Nurses Ease the Wounded Heart 3Health News:Nurses Ease the Wounded Heart 4
(Date:11/26/2014)... NEW YORK , Nov. 25, 2014 /PRNewswire/ ... with Covidien has been widely discussed in ... but it,s also creating a stronger leading player ... according to Kalorama Information.  The healthcare market research ... monitoring systems will feature a diverse set of ...
(Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
(Date:11/26/2014)... and LONDON , Nov. 25, ... AstraZeneca (NYSE: AZN ) today announced that AMAGINE-2 ... doses of brodalumab in more than 1,800 patients with moderate-to-severe ... Stelara ® (ustekinumab) and placebo at week 12. Brodalumab ... analysis group were each shown to be superior to Stelara ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... of choice for certain newly diagnosed patients with chronic myeloid leukemia , ... of cancer cells in 96% of Tasigna patients and reduction of abnormal ... Larger front-line Phase III trial evaluating Tasigna vs. Gleevec(R) now fully accrued ... , EAST HANOVER, N.J., Dec. 8 ...
... SAN FRANCISCO, Dec. 8 Millennium: The ... two large, multi-center,randomized Phase III clinical trials ... of transplant-eligible patients with previously untreated,multiple myeloma ... one study comparing VELCADE and dexamethasone (VcD) ...
Cached Medicine Technology:Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 2Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 3Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 4Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 5Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 6Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 7Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 8Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 9Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 10Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 11Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 12Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 13Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 2Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 3Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 4Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 5Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 6Prolonged Progression-Free Survival Demonstrated by VELCADE(R) (Bortezomib) for Injection Based Induction Regimens in Transplant-Eligible Previously Untreated Multiple Myeloma Patients 7
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: